TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,201,586
|
3,156,045
|
3,564,331 |
| Earnings before taxes |
-230,778
|
476,648
|
1,087,801 |
| Total assets |
6,015,591
|
5,465,294
|
4,868,654 |
| Current assets |
1,617,366
|
1,807,936
|
2,054,643 |
| Current liabilities |
2,313,544
|
3,288,822
|
2,745,173 |
| Equity capital |
1,016,328
|
463,666
|
936,066 |
| - share capital |
68,048
|
64,632
|
60,660 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
16.9%
|
8.5%
|
19.2% |
| Turnover per employee |
9,147
|
9,017
|
10,184 |
| Profit as a percentage of turnover |
-7.2%
|
15.1%
|
30.5% |
| Return on assets (ROA) | |||
| Current ratio |
69.9%
|
55.0%
|
74.8% |
| Return on equity (ROE) |
-22.7%
|
102.8%
|
116.2% |
| Change turnover |
-121,272
|
-641,643
|
471,323 |
| Change turnover % |
-4%
|
-17%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.